期刊文献+

FLT3-ITD突变检测及其临床意义 被引量:4

下载PDF
导出
摘要 Fms样酪氨酸激酶-3(fms-like tyrosine kinase-3,FLT3)是Ⅲ型受体酪氨酸激酶家族成员,在约20%-30%的急性髓系白血病(acute myeloid leukemia,AML)患者中FLT3基因中外显子14和15存在内部串联重复(FLT3 in-tema]tandemduplication,FLT3-ITD),近年来对于FLT3突变的检测、预后意义以及FLT3抑制剂的应用研究比较深入.本文对此作一综述。
作者 马亮 马一盖
出处 《中日友好医院学报》 2011年第3期178-180,184,共4页 Journal of China-Japan Friendship Hospital
  • 相关文献

参考文献25

二级参考文献32

  • 1王莉红,周春林,张新伟,陈森,王敏,王建祥.FLT3基因内部串联重复突变与急性白血病的关系及临床意义[J].中华血液学杂志,2004,25(7):393-396. 被引量:35
  • 2王彤,王杰.白血病患者Flt-3基因突变检测及临床意义[J].中华血液学杂志,2006,27(11):766-767. 被引量:2
  • 3Mathews W, Jordan CT, Wiegand GW, et al. A receptor tyrosine kinase specific to haematopoietic stem and progenitor cell-enriched populations [J]. Cell, 1991,65: 1143. 被引量:1
  • 4Stirewalt DL, Radich J P. The role of FL T3 in haematopoietic malignancies[ J]. Nat Rev Cancer, 2003,3 : 650. 被引量:1
  • 5Kiyoi H, Naoe T, Nakano Y, et al. Prognostic implication of FLT3and N2RAS gene mutations in acute myeloid leukemia[ J]. Blood, 1999,93: 3074. 被引量:1
  • 6Kiyoi H, Towatari M, Yokota S, et al. Internal tandem duplicationof the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product[J]. Leukemia, 1998,12:1333. 被引量:1
  • 7Kainz B, Heintel D, Marculescu R, et all Variable prognostic value ofFLT3 internal tandem duplications in patientswith de novo AML anda normal karyotype,t(15;17),t(8;21) or inv (16) 1[J].Hematol J,2002,3:283. 被引量:1
  • 8Nakao M,Janssen JW,Erz D,et al. Tandem duplication of the FLT3 gane in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease[ J ]. Leukemia, 2000,14: 522. 被引量:1
  • 9Ciolli S, Vannucchi AM, Leoni F, et all Internal tandem duplicationsof FLT3 gene (FLT3/ITD) predicts a poor postremission outcome inadult patients with acute non-promyelocytic leukemialLeuk Lymphoma,2004, .45:73 - 78. 被引量:1
  • 10Yamamoto Y, Kiyoi H, Nakano Y, et al. Activating matation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 2001, 97: 2434-2439. 被引量:1

共引文献27

同被引文献39

  • 1王莉红,周春林,张新伟,陈森,王敏,王建祥.FLT3基因内部串联重复突变与急性白血病的关系及临床意义[J].中华血液学杂志,2004,25(7):393-396. 被引量:35
  • 2管考鹏,马建辉,孙燕.索拉非尼的毒副作用及处理[J].癌症进展,2007,5(4):370-373. 被引量:39
  • 3KOTTARIDIS P D, GALE R E, FREW M E, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds im- portant prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials[J]. Blood, 2001,98 : 1752-- 1759. 被引量:1
  • 4MESHINCHI S,WOODS W G,STIREWALT D L,et al. Prevalence and prognostic significance of Flt3 inter- nal tandem duplication in pediatric acute myeloid leu- kemia[J]. Blood, 2001,97 : 89-- 94. 被引量:1
  • 5ZHANG W, KONOPLEVA M, SHI Y X, et al. Mu tant FLT3:a direct target of sorafenib in acute my elogenous leukemia[J]. J Natl Cancer Inst, 2008,100 184--198. 被引量:1
  • 6CH()UDHARY C, MULLER-TIDOW C, BERDEL W E,et al. Signal transduction of oncogenic Flt3[J]. Int J Hematol, 2005,82 : 93 -- 99. 被引量:1
  • 7PRATZ K W,SATO T,MURPHY K M,et al. FLT3- mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML[J]. Blood, 2010,115 : 1425-- 1432. 被引量:1
  • 8SAFAIAN N N, CZIBERE A, BRUNS I, et al. Sor- afenib (Nexavar) induces molecular remission and re- gression of extramedullary disease in a patient with FLT3 ITD+ acute myeloid leukemia[J]. Leuk Res, 2009,33:348--350. 被引量:1
  • 9METZELDER S, WANG Y, WOLLMER E, et al. Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation [J]. Blood, 2009,113 ~ 6567-- 6571. 被引量:1
  • 10RAVANDI F, CORTES JE, JONES D, et al. Phase I/ II study of combination therapy with sorafenib,idaru- bicin, and cytarahine in younger patients with acute myeloid leukemia[J]. J Clin Oncol, 2010,28: 1856- 1862. 被引量:1

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部